Literature DB >> 2535770

Primary liver tumors: diagnosis by MR imaging.

E Rummeny1, R Weissleder, D D Stark, S Saini, C C Compton, W Bennett, P F Hahn, J Wittenberg, R A Malt, J T Ferrucci.   

Abstract

MR features of 153 proved primary liver tumors (95 malignant, 58 benign) in 55 patients with hepatocellular carcinoma (21), cholangiocarcinoma (seven), carcinosarcoma (one), hepatoblastoma (one), hemangioma (16), hepatic adenoma (four), focal nodular hyperplasia (three), leiomyoma (one), and hemangioendothelioma (one) were studied retrospectively to determine which techniques are most reliable for lesion detection and which criteria are most useful for differential diagnosis. MR data were correlated with histologic features such as fatty degeneration, fibrosis, and peritumoral edema. Unlike metastatic cancer, hepatocellular carcinoma was best detected (p less than .01) with T2-weighted pulse sequences. The mean tumor-liver T2 difference was 34.4%, while the mean T1 difference was only 21.8%. A tissue-specific diagnosis of hepatocellular carcinoma was possible in 14 of 21 patients by identification of fatty degeneration of the tumor (eight of 17), tumor capsule (five of 21), and/or vascular invasion (six of 21). MR features of peritumoral edema, present in six of 21 patients with hepatocellular carcinoma and in seven of 25 patients with metastases, were exclusively associated with malignant tumors. The large variation in tissue characteristics (relaxation times and proton density) seen in primary liver tumors necessitates the use of multiple pulse sequences to maximize lesion detection. However, the combined use of T1- and T2-weighted spin-echo and T2-weighted phase-contrast images had the advantage of distinguishing benign from malignant primary liver tumors in 48 of 55 patients in this series.

Entities:  

Mesh:

Year:  1989        PMID: 2535770     DOI: 10.2214/ajr.152.1.63

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  19 in total

1.  Smooth muscle tumor arising de novo in a liver allograft: A case report.

Authors:  Howard Doyle; Andreas G Tzakis; Eduardo Yunis; Thomas E Starzl
Journal:  Clin Transplant       Date:  1991-02       Impact factor: 2.863

2.  Carcinosarcoma of the liver: a case report.

Authors:  Jung Hyeok Kwon; Yu Na Kang; Koo Jeong Kang
Journal:  Korean J Radiol       Date:  2007 Jul-Aug       Impact factor: 3.500

Review 3.  Primary leiomyoma of the liver. A case report and review of the literature.

Authors:  T E Reinertson; J B Fortune; J C Peters; I Pagnotta; J A Balint
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

4.  Controversies in imaging of hepatocellular carcinoma: multidetector CT (MDCT).

Authors:  Paul M Silverman; Janio Szklaruk
Journal:  Cancer Imaging       Date:  2005-12-10       Impact factor: 3.909

5.  Mosaic pattern of encapsulated hepatocellular carcinoma: correlation of magnetic resonance imaging and pathology.

Authors:  B I Choi; G K Lee; S T Kim; M C Han
Journal:  Gastrointest Radiol       Date:  1990

6.  Tissue characterisation of atherosclerotic carotid plaques by MRI.

Authors:  M Görtler; A Goldmann; W Mohr; B Widder
Journal:  Neuroradiology       Date:  1995-11       Impact factor: 2.804

Review 7.  Liver-Directed Radiotherapy for Hepatocellular Carcinoma.

Authors:  Florence K Keane; Jennifer Y Wo; Andrew X Zhu; Theodore S Hong
Journal:  Liver Cancer       Date:  2016-05-10       Impact factor: 11.740

8.  Long-term follow-up of hepatic adenoma and adenomatosis: analysis of size change on imaging with histopathological correlation.

Authors:  N Shao; A Pandey; M A Ghasabeh; P Khoshpouri; P Pandey; F N Varzaneh; M Zarghampour; D Fouladi; T M Pawlik; R A Anders; I R Kamel
Journal:  Clin Radiol       Date:  2018-07-18       Impact factor: 2.350

9.  Biliary carcinosarcoma arising in nonparasitic simple cyst of the liver.

Authors:  T Terada; K Notsumata; Y Nakanuma
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 10.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.